Fossil Group, Inc. Reports Third Quarter Fiscal Year 2017 Results
Nov 07, 2017 21:01 pm UTC| Business
Third Quarter Net Sales of $689 Million and GAAP Diluted EPS (Loss) of $(0.11); Provides Fourth Quarter and Updates Annual Fiscal 2017 GAAP Guidance RICHARDSON, Texas, Nov. 07, 2017 -- Fossil Group, Inc....
Pernix Therapeutics Reports Third Quarter 2017 Financial Results
Nov 07, 2017 21:01 pm UTC| Business
MORRISTOWN, N.J., Nov. 07, 2017 -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, announced today financial results for the third quarter ended September...
Calix Reports Third Quarter 2017 Financial Results
Nov 07, 2017 21:01 pm UTC| Business
PETALUMA, Calif., Nov. 07, 2017 -- Calix, Inc. (NYSE:CALX) today announced unaudited financial results for the third quarter ended September 30, 2017. Revenue for the third quarter of 2017 was a third quarter record...
Performant Financial Corporation Announces Financial Results for Third Quarter 2017
Nov 07, 2017 21:01 pm UTC| Business
LIVERMORE, Calif., Nov. 07, 2017 -- Performant Financial Corporation (Nasdaq:PFMT), a leading provider of technology-enabled recovery and related analytics services in the United States, today reported the following...
Blue Buffalo Reports Third Quarter 2017 Results
Nov 07, 2017 21:01 pm UTC| Business
WILTON, Conn., Nov. 07, 2017 -- Blue Buffalo Pet Products, Inc. (the “Company”) (NASDAQ:BUFF), the leading natural pet food company in the United States, today announced its third quarter 2017 results. Third Quarter...
MannKind Corporation Reports 2017 Third Quarter Financial Results
Nov 07, 2017 21:01 pm UTC| Business
WESTLAKE VILLAGE, Calif., Nov. 07, 2017 -- MannKind Corporation (NASDAQ:MNKD) today reported financial results for the third quarter and the nine months ended September 30, 2017. Third quarter highlights include: ...
Depomed and Slán Medicinal Holdings Ltd Announce Strategic Asset Transactions
Nov 07, 2017 21:00 pm UTC| Business
-Depomed to Acquire Cosyntropin Depot from Slán Medicinal Holdings Limited Creating New Specialty Pharmaceutical Business - - Slán Medicinal Holdings Limited to Acquire Lazanda® from Depomed - NEWARK, Calif., Nov. 07,...